Effects of Adjuvant Treatment of Spleen Amino Peptide Oral Liquid on Cellular Immunity and Inflammatory Factors in Children with Severe Pneumonia

Qiao Jian

doi:10.13407/j.cnki.jpp.1672-108X.2020.10.009

您当前的位置：

首页 >

文章列表页 >

Effects of Adjuvant Treatment of Spleen Amino Peptide Oral Liquid on Cellular Immunity and Inflammatory Factors in Children with Severe Pneumonia

更新时间：2022-11-03

- Effects of Adjuvant Treatment of Spleen Amino Peptide Oral Liquid on Cellular Immunity and Inflammatory Factors in Children with Severe Pneumonia
- Vol. 26, Issue 10, Pages: 26-29(2020)
- 作者机构：
  
  徐州儿童医院,江苏,徐州,221000
- 作者简介：
- 基金信息：
- DOI：10.13407/j.cnki.jpp.1672-108X.2020.10.009
  CLC：
- Published：2020，
  
  Published Online：10 October 2020，
扫描看全文
Qiao Jian. Effects of Adjuvant Treatment of Spleen Amino Peptide Oral Liquid on Cellular Immunity and Inflammatory Factors in Children with Severe Pneumonia. [J]. 26(10):26-29(2020)
DOI：

Qiao Jian. Effects of Adjuvant Treatment of Spleen Amino Peptide Oral Liquid on Cellular Immunity and Inflammatory Factors in Children with Severe Pneumonia. [J]. 26(10):26-29(2020) DOI： 10.13407/j.cnki.jpp.1672-108X.2020.10.009.

摘要

目的：探讨脾氨肽口服液辅助治疗对重症肺炎患儿细胞免疫及炎性因子的影响。方法：选取徐州儿童医院2016年2月至2018年3月收治的重症肺炎患儿85例，按完全随机化方法分为常规组（n=42）和联合组（n=43），常规组采用常规西药治疗，联合组采用脾氨肽口服液配合常规西药治疗，比较治疗前后细胞免疫及炎性因子变化、临床疗效和药物不良反应。结果：治疗后两组患儿CD4+、CD4+/CD8+均升高（P<0.05），CD8+、血清IL-10、IL-17和TGF-β1水平均降低（P<0.05）；联合组CD4+、CD4+/CD8+均高于常规组（P<0.05），CD8+、血清IL-10、IL-17和TGF-β1水平均低于常规组（P<0.05）。联合组总有效率为97.67%，高于常规组的86.71%，两组比较差异有统计学意义（P<0.05）；两组药物不良反应发生率比较差异无统计学意义（P>0.05）。结论：对重症肺炎患儿给予脾氨肽口服液辅助治疗能够改善细胞免疫指标，控制炎性因子水平，增强临床疗效，且未增加药物不良反应。

Abstract

Objective: To probe into the effects of adjuvant treatment of spleen amino peptide oral liquid on cellular immunity and inflammatory factors in children with severe pneumonia. Methods: A total of 85 children with severe pneumonia admitted to Xuzhou Children’s Hospital from Feb. 2016 to Mar. 2018 were randomly divided into the routine group (n=42) and the combined group (n=43). The routine group was treated with routine western medicine

while the combined group received spleen amino peptide oral liquid combined with routine western medicine. Changes of cellular immunity and inflammatory factors before and after treatment

clinical efficacy and adverse drug reactions of two groups were compared. Results: After treatment

the levels of CD4+

CD4+/CD8+ increased in both groups (P<0.05)

while the levels of CD8+

IL-10

IL-17 and TGF-β1 decreased (P<0.05). The levels of CD4+ and CD4+/CD8+ in the combined group were higher than those in the routine group (P<0.05)

and the levels of CD8+

IL-10

IL-17 and TGF-β1 were lower than those in the routine group (P<0.05). The total effective rate of the combined group was 97.67%

higher than 86.71% of the routine group

and the difference was statistically significant (P<0.05). There was no significant difference in the incidence of adverse drug reactions between two groups (P>0.05). Conclusion: Adjuvant treatment of spleen amino peptide oral liquid in the treatment of children with severe pneumonia can improve the cellular immunity

control the levels of inflammatory factors

enhance the clinical efficacy

with lower incidence of adverse drug reactions.

关键词

脾氨肽口服液重症肺炎细胞免疫炎性因子

Keywords

spleen amino peptide oral liqusevere pneumoniacellular immunitynflammatory factors

references

查看原文

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Efficacy Evaluation of Human Immunoglobulin Combinded with Methylprednisolone in the Treatment of Severe Pneumonia in Children

Meta-Analysis of Efficacy and Safety of Milrinoneon Injection in the Treatment of Children with Congenital Heart Disease Complicated with Severe Pneumonia and Heart Failure

Evaluation Value of Fibrin Degradation Products, Monocyte/Lymphocyte Ratio and Neutrophils/Lymphocyte Ratio in Peripheral Blood for Prognosis of Children with Severe Pneumonia

Clinical Effects of Clopidogrel in Adjuvant Treatment of Children with Intravenous Immunoglobulin-Resistant Kawasaki Disease

Changes of Immunization Levels in Children with Infantile Spasm before and after Adrenocorticotropic Hormone Therapy

Related Author

Wang Xialin

Hu Gaosheng

Zhang Dufei

Wang Yazhou

Zhang Xiangyu

Mao Guoqi

Zheng Yinglian

Xia Hong

Related Institution

Xiamen Children’s Hospital

Hainan Women and Children’s Medical Center, Children’s Hospital of Hainan

Dazu Hospital, The First Affiliated Hospital of Chongqing Medical University, The People’s Hospital of Dazu

Xiaochang First People’s Hospital

Children’s Hospital of Hebei Province

⁰